Senior Director, Medical Affairs Strategy & Launch--Hematology
Sumitomo Pharma America, Inc.
Summary
The Senior Director, Medical Strategy, Hematologic Malignancies & Launch Readiness reports to the VP of Medical Affairs and is part of the Medical Affairs team. The role is responsible for supporting the development and execution of the medical affairs launch strategy for investigational and medical strategy for marketed hematology-oncology assets. This individual serves as a scientific and strategic leader within Medical Affairs, integrating external insights, clinical evidence, disease state knowledge, and cross-functional perspectives to deliver impactful medical initiatives across the product lifecycle.
Job description
Essential Functions
Medical Strategy Leadership
- Support the development and implementation of comprehensive Medical Affairs strategies for hematologic malignancy assets and disease areas.
- Contribute to annual medical planning, strategic imperatives, and execution of tactical activities aligned with corporate objectives.
- Monitor evolving scientific, clinical, and competitive landscapes and translate insights into actionable medical strategies.
- Serve as the Medical Affairs representative on cross-functional product teams and launch teams.
Scientific Leadership & External Engagement
- Build and maintain strategic scientific relationships with key opinion leaders (KOLs), investigators, professional societies, and patient advocacy organizations.
- Lead external advisory boards and scientific exchange activities to gather actionable insights that inform strategy.
- Represent Medical Affairs at scientific congresses, hematology meetings, and other external scientific forums.
- Provide scientific leadership to support disease-state education and stakeholder engagement initiatives.
Evidence Generation & Insights
- Partner with Clinical Development, Health Economics and Outcomes Research (HEOR), and Real-World Evidence (RWE) teams to identify evidence gaps and support data generation strategies.
- Contribute to investigator-sponsored research (ISR/IIS) strategy, scientific review, and oversight activities.
- Support development and execution of publication plans and scientific dissemination strategies.
- Synthesize and analyze insights from field interactions, advisory boards, congresses, and stakeholder engagements to refine medical strategy and tactical execution.
Launch Excellence & Lifecycle Management
- Support launch readiness planning and execution for pipeline and marketed assets within hematologic malignancies.
- Develop scientific platforms and core medical messages that communicate clinical value, differentiation, and unmet need.
- Partner with Medical Communications and Training functions to ensure scientific consistency across medical materials and field resources.
- Identify opportunities to strengthen asset differentiation through evidence generation and stakeholder engagement strategies.
Cross-Functional Collaboration & Compliance
- Collaborate effectively across Medical Affairs functions, including Field Medical, Medical Communications, Medical Information, HEOR/RWE, and Medical Excellence.
- Provide strategic medical input into congress planning, educational initiatives, and stakeholder engagement activities.
- Ensure all activities are conducted in compliance with applicable laws, regulations, company policies, and industry standards.
Requirements
- Advanced scientific or clinical degree required (PharmD, PhD, MD, DO, DNP, or equivalent). MD or PharmD preferred
- Minimum 12 years of relevant experience in biotech or pharmaceutical industry
- Minimum 7 years of Medical Affairs experience in oncology and/or hematology.
- Demonstrated experience developing and executing medical strategies.
- Strong knowledge of hematologic malignancies, clinical research, and evidence generation.
- Experience engaging with KOLs, investigators, and external stakeholders.
- Excellent communication, presentation, and scientific storytelling skills.
- Strong project management and cross-functional leadership capabilities.
Benefits
- 401(k) plan
- Medical insurance
- Dental insurance
- Vision insurance
- Life insurance
- Disability insurance
- Flexible paid time off
- 11 paid holidays
- Paid sick time
Company overview
Sumitomo Pharma America, Inc. (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. Formed in July 2023 through the consolidation of Sumitomo Pharma's U.S. affiliate companies, SMPA represents the integrated North American operations of the Japanese pharmaceutical giant. The company operates across multiple therapeutic areas including oncology, urology, women's health, rare disease, cell and gene therapies, and central nervous system disorders. With a diverse portfolio that includes six marketed products and a robust pipeline of early- to late-stage assets, SMPA leverages proprietary advanced analytics and computational technology platforms to accelerate drug discovery and development. Headquartered in Marlborough, Massachusetts, the company employs approximately 2,200 people and maintains a strong focus on maximizing the value of key products like ORGOVYX®, MYFEMBREE®, and GEMTESA® while advancing innovative treatments for unmet medical needs.